Thermo Fisher Scientific Inc. (NYSE:TMO)

The valuation ratios exhibit a period of expansion peaking in mid-2024, followed by a notable contraction and subsequent volatility through early 2026. A consistent correlation is observed across all four metrics, suggesting that market sentiment and valuation adjustments shifted uniformly across earnings, operating profit, sales, and book value.

Earnings and Operating Profit Valuations

The Price to Earnings (P/E) and Price to Operating Profit (P/OP) ratios followed nearly identical trajectories. Both ratios climbed from 2022 levels to reach peaks in June 2024, with the P/E ratio hitting 37.81 and the P/OP ratio reaching 32.66. A sharp correction occurred by March 2025, where the P/E ratio dropped to 24.55 and the P/OP ratio to 21.64. While a moderate recovery was seen in late 2025, both ratios ended the period in March 2026 at levels comparable to or lower than their 2022 baselines, with the P/E at 25.46 and P/OP at 22.09.

Revenue-Based Valuation

The Price to Sales (P/S) ratio remained relatively stable between 4.05 and 5.55 for the majority of the period. A peak of 5.55 was recorded in June 2024, mirroring the trends seen in earnings multiples. However, a significant decline was observed starting in late 2024, reaching a low of 3.73 in March 2025. The ratio concluded the period at 3.86, indicating a reduction in the premium the market is willing to pay per unit of revenue compared to the 2022-2024 period.

Asset-Based Valuation

The Price to Book Value (P/BV) ratio demonstrates a general downward trend over the long term. After starting at 5.23 in April 2022 and peaking at 5.47 in July 2022, the ratio experienced a steady decline with occasional fluctuations. The most significant compression occurred in March 2025, when the ratio fell to 3.24. Despite a brief increase in late 2025, the ratio ended at 3.36 in March 2026, representing a substantial decrease in valuation relative to shareholders' equity.

The synchronicity of the troughs in March 2025 across all ratios suggests a systemic re-rating of the company's valuation multiples during that quarter. The overall movement indicates that after a period of valuation inflation ending in mid-2024, the stock has transitioned to a more conservative valuation framework by early 2026.

The valuation trajectory of the common stock exhibits significant volatility, characterized by a period of valuation expansion followed by a marked contraction and subsequent stabilization.

Earnings Per Share (EPS) Performance

Earnings followed a U-shaped trajectory, starting at 19.42 in April 2022 and declining to a trough of 14.82 by July 2023. Following this low point, a consistent and sustained recovery trend is observed, with EPS steadily climbing to 18.43 by March 2026. This indicates a successful rebound in fundamental profitability over the latter half of the analyzed period.

Share Price Dynamics

The share price experienced considerable fluctuations, reaching a peak of 615.69 in June 2024. A subsequent downward trend emerged, characterized by a sharp decline to 423.55 in March 2025. Despite a temporary recovery to 567.39 in September 2025, the price ended the period at 469.21, reflecting a general decline from the peaks observed in 2024.

Price-to-Earnings (P/E) Ratio Analysis

The P/E ratio expanded from 28.15 in April 2022 to a maximum of 37.81 in June 2024. This peak occurred during a phase where the share price reached its highest point while earnings were still recovering from their 2023 lows, suggesting a period of premium valuation. A significant contraction followed, with the ratio dropping to 24.55 in March 2025. The period concluded with a P/E of 25.46, indicating a valuation compression and a shift toward a more conservative multiple.

Overall, a divergence is observed between earnings growth and market valuation. While fundamental earnings showed a steady recovery from mid-2023 through early 2026, the P/E ratio peaked in mid-2024 and subsequently declined. This suggests that the market's willingness to pay a premium for each dollar of earnings decreased over the final stages of the period, despite the improvement in actual earnings per share.

An analysis of the Price to Operating Profit (P/OP) ratio reveals a period of significant valuation expansion followed by a correction toward historical baselines. The ratio shifted from a relatively stable range in 2022 to a peak in mid-2024, before trending downward through early 2026.

Operating Profit per Share Trends

Operating profit per share exhibited a distinct U-shaped trajectory. Starting at a high of 25.03 USD in April 2022, the metric experienced a consistent decline, reaching a trough of 17.39 USD by July 2023. Following this low point, a gradual and steady recovery was observed, with the value climbing back to 21.24 USD by March 2026.

Valuation Multiple Expansion

The P/OP ratio underwent a substantial expansion during 2023 and the first half of 2024. While the ratio averaged between 21.43 and 25.30 in 2022, it surged to a peak of 32.66 by June 2024. This increase occurred despite the concurrent decline in operating profit per share, indicating that the share price remained resilient or grew independently of short-term operating performance, thereby inflating the valuation multiple.

Price and Ratio Convergence

A contraction in the P/OP ratio began in the second half of 2024 and continued through March 2026. This downward trend was driven by a combination of share price volatility and the recovery of operating profits. The ratio decreased from its peak of 32.66 to 22.09 by the end of the period. This movement suggests a normalization of the valuation, as the market price aligned more closely with the improving fundamental operating performance.

Correlation Analysis

An inverse relationship was observed between operating profit per share and the P/OP ratio during the 2023-2024 window, where falling profits contributed to a higher multiple. However, in the 2025-2026 period, the rising operating profit per share acted as a stabilizer, facilitating a return to a valuation multiple consistent with the levels observed at the start of the analysis period.

The analysis of the Price-to-Sales (P/S) ratio reveals a period of valuation volatility characterized by a divergence between fundamental revenue growth and market pricing. While sales per share maintained a consistent upward trajectory over the analyzed timeframe, the P/S ratio experienced several cycles of expansion and contraction, indicating that fluctuations in the share price exerted a more significant influence on the valuation multiple than the growth in underlying sales.

Price-to-Sales (P/S) Ratio Volatility

The P/S ratio exhibited significant variance, peaking at 5.55 in June 2024 before declining to a period low of 3.73 in March 2025. This contraction represents a substantial reduction in the multiple investors were willing to pay per dollar of sales, suggesting a market re-rating of the company's revenue streams during the 2024-2025 period.

Sales per Share Growth Patterns

Fundamental revenue performance per share demonstrated steady growth, increasing from 105.05 in April 2022 to 121.62 by March 2026. Although growth slowed between September 2023 and December 2024, the overall trend remained positive, reflecting a gradual increase in the company's ability to generate sales on a per-share basis.

Valuation Divergence and Correlation

A clear divergence is observed in the latter part of the series. Between March 2025 and March 2026, sales per share rose from 113.64 to 121.62; however, the P/S ratio remained compressed, ending at 3.86. This indicates that the valuation multiple did not recover in tandem with the increase in sales, as the share price failed to return to its 2022-2024 peaks.

Share Price Influence

The fluctuations in the P/S ratio are primarily driven by share price volatility. The highest valuation multiple in June 2024 coincided with a share price peak of 615.69. Conversely, the valuation troughs in March 2025 and March 2026 were directly correlated with share price declines to 423.55 and 469.21, respectively, despite the improving sales per share figures.

The Price to Book Value (P/BV) ratio for the analyzed period exhibits a general downward trajectory characterized by significant volatility, reflecting a shift in market valuation relative to the company's accounting book value.

Book Value Per Share (BVPS) Trend

A consistent upward trajectory is observed in the book value per share, which increased from 104.62 USD in April 2022 to 139.75 USD by March 2026. This growth indicates a steady accumulation of net assets on a per-share basis, providing a strengthening fundamental floor for the valuation.

Share Price Volatility

The share price experienced substantial fluctuations throughout the period, reaching a peak of 615.69 USD in June 2024 and a low of 423.55 USD in March 2025. This volatility served as the primary driver for the fluctuations observed in the P/BV ratio, as the market price moved more aggressively than the underlying book value.

P/BV Ratio Dynamics

The valuation multiple peaked at 5.47 in July 2022. Following this peak, the ratio largely fluctuated between 4.0 and 5.0 until late 2024. A significant compression in the multiple occurred in early 2025, with the ratio descending to a period low of 3.24 in March 2025. Despite a brief recovery to 4.18 in June 2025, the ratio remained subdued, ending the period at 3.36 in March 2026.

Valuation Analysis

The divergence between a steadily rising book value and a volatile share price resulted in an overall contraction of the P/BV multiple. The transition from a valuation peak exceeding 5.0 to a closing range between 3.2 and 3.6 suggests a market repricing, where the premium attributed to the company's assets decreased over the four-year period.